MariMed Inc. (MRMD) Reports In-Line Q1 EPS; Offers FY23 Revenue Guidance

MariMed Inc. (OTC: MRMD) reported Q1 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $36.5 million versus the consensus estimate of $35.9 million.

GUIDANCE:

MariMed Inc. sees FY2023 revenue of $150 million, versus the consensus of $151.5 million.

For earnings history and earnings-related data on MariMed Inc. (MRMD) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Innovaro (INV) Misses Q2 EPS by 9c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c